Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Less‑intensive therapy in newly diagnosed acute myeloid leuekmia (AML) in India: Real-world adoption and prognostic utility of ELN‑LI and ELN‑2022 classification

Blood (2025) 146 (Supplement 1): 2829.

https://doi.org/10.1182/blood-2025-2829

Published: 2025

Journal Articles

Pediatric inspired (BFM) protocol in adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL) in India: Real‑world treatment timelines and impact of delays on survival

Blood (2025) 146 (Supplement 1): 8049.

https://doi.org/10.1182/blood-2025-8049

Published: 2025

Journal Articles

Early use of talicabtagene autoleucel in r/r B-acute lymphoblastic leukemia is cost-effective: Improved efficacy, reduced toxicity and healthcare resource utilization support affordable access

Atharva Karulkar, Hasmukh Jain, Devanshi Kalra, Smrithi Ravikumar, Anand Vaibhaw, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Neeraj Siddarthan, Pavan Kumar Boyella, Sanket Shah, Sameer Melinkeri, Anshul Gupta, Prashant Mehta, Chandran Nair, Dinesh Bhurani, Akshay Lahoti, Anupam Chakrapani, Balakrishna Padate, Prakash Shekhawat, Priyanka Samal, Rajat Bajaj, Rumesh Chandar, Padmaja Lokireddy, Anil Aribandi, Bhausaheb Bagal, Girish Badarkhe, Jayachandran P.K., Kripa Bajaj, Nataraj KS, Nishad Dhakate, Rajan Kapoor, Rahul Bhargava, Sameer Tulpule, Sharat Damodar, Sunil Gupta, Suraj Chiraniya, Suvir Singh, Rajasekar Thirugnanam, Vasu Babu Goli, Vikram Mathews, Esha Kaul, Krishna Reddy Golamari, Kannan Subramanian, Lingaraj Nayak, Alok Shetty, Aditya Murali, Punit Jain, Rajat Bhattacharyya, Rakesh Boya, Ram Abhinav, Velu Nair, Hari Menon, Monisha Harimadhavan, Mohammed Sadique Ansari, Nishant Tiwari, Shamil Darbar, Supriya Chawkekar, Sushmita Sahay, Manivasagam Sundharam, Ashish Saroha, Moumita Basu, Anjali Jaiswal, Yuktam Yadav, Sakshi Soni, Jayshree Thorat, Shalini Purwar, Nirali Shah, Terry Fry, Nitin Jain, Manju Sengar, Rahul Purwar

Blood (2025) 146 (Supplement 1): 1076.

https://doi.org/10.1182/blood-2025-1076

Published: 2025

Journal Articles

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.

Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Anand Vaibhaw, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Sameer Melinkeri, Rahul Bhargava, Neeraj Siddarthan, Dr Dinesh Bhurani, Jayachandran P.K., Esha Kaul, Prashant Mehta, Hari Menon, Bhausaheb Bagal, Kunal Goyal, Prakash Shekhawat, Pavan Kumar Boyella, Rakesh Boya, Ram Abhinav, Rayaz Ahmed, Anil Aribandi, Ashwin V Nair, Chandran Nair, Harish Palaparthi, Lingaraj Nayak, Pawan Singh, Priyanshi Pachauri, Rajat Bhattacharya, Rajiv Kumar, Ranjit Sahoo, Sharat Damodar, Vikram Mathews, Vasu Babu Goli, Abhishek Charan, Ajay Gupta, Amul Kapoor, Anupam Chakrapani, Ashish Bakshi, Bijay Prabhakaran Nair, Bilal Kazi, Debranjani Chattopadhyay, Ganesh S. Jaishetwar, Kaushal Kalra, Kishore Kumar, Lekshmon K.S, Madhav Danthala, Mallikarjun Kalashetty, Narendra Anukonda, Naveen Gupta, Nivedita Dhingra, Padmaja Lokireddy, Prasad Narayanan, Parathan Karunakaran, Prasanth Ganesan, Punit Jain, Priyanka Samal, Ramaswamy N.V., Rajan Kapoor, Shyam Aggarwal, Roy J Palatty, Sainath Bhethanabhotla, Sachin Almel, Santhosh Devadas, Sivakumaran Janakiraman, Sudeep V, Sreeraj Vasudevan, Sameer Tulpule, Suraj Chiraniya, Vijay Patil, Sumita Chaudhry, T Raja, Sunu Cyriac, Shishir Seth, Chezhian Subash, Varun Rajan, Alok Shetty, Vishwanath Sathyanarayanan, Mohammed Sadique Ansari, Nishant Tiwari, Shamil Darbar, Supriya Chawkekar, Sushmita Sahay, Manivasagam Sundharam, Ashish Saroha, Moumita Basu, Anjali Jaiswal, Yuktam Yadav, Sakshi Soni, Jayashree Thorat, Shalini Purwar, Nirali Shah, Terry Fry, Nitin Jain, Sattva Neelapu, Manju Sengar, Rahul Purwar

Blood (2025) 146 (Supplement 1): 6288.

https://doi.org/10.1182/blood-2025-6288

Published: 2025

Journal Articles

Real World Data of Novel Talicabtagene Autoleucel (humanized CD19 CAR-T) from India; Ensuring Equitable Access with Excellent Safety and Efficacy Profile

Blood (2024) 144 (Supplement 1): 3755.

https://doi.org/10.1182/blood-2024-202335

Published: 2024

Journal Articles

CD 19 CAR T-Cell Therapy in R/R B Cell Malignancies : A Real World Experience from CAR T Working Group, Delhi Ncr ,India

Prashant Mehta, Pravas Mishra, Dinesh Bhurani, Vidit Kapoor, Esha Kaul, Rayaz Ahmed, Saphalta Baghmar, Swati Pabbi, Rahul Katharia, Nupur Das, Narendra Agrawal, Rohan Halder, Roy Palatty, Reema Singh, Faran Naim, Jagsahib Kaur

Blood (2024) 144 (Supplement 1): 7772.

https://doi.org/10.1182/blood-2024-205903

Published: 2024

Journal Articles

Photopheresis As Part of Conditioning Reduces Incidence of Severe Graft Versus Host Disease: Fourteen Year Follow-up of a Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Esha Kaul, MD, Gunjan L Shah, MDMS, Aaron S. Rosenberg, MD, Raymond L. Comenzo, MD, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Furha I. Cossor, MD, Grace S. Kao, MD, Kenneth B. Miller, MD, Andreas K. Klein, MD, Kellie A. Sprague, MD

Blood (2014) 124 (21): 5924.

https://doi.org/10.1182/blood.V124.21.5924.5924

Published: 2014

Journal Articles

Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis

Ojas H. Vyas, MD, Esha Kaul, MD, Aaron S. Rosenberg, MD, Gunjan L Shah, MDMS, Urvi Ajay Shah, MD, Raymond L. Comenzo, MD, Grace Shih-Hui Kao, MD, Andrew M. Evens, DO, MSc, Hedy Smith, MDPhD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Kellie A. Sprague, MD

Blood (2014) 124 (21): 3170.

https://doi.org/10.1182/blood.V124.21.3170.3170

Published: 2014

Journal Articles

Plerixafor and G-CSF For Autologous Stem Cell Mobilization In AL Amyloidosis: A Single Center Experience

Esha Kaul, MD, Gunjan L Shah, MD MS, Chakra P Chaulagain, MD, FACP, Raymond L. Comenzo, MD

Blood (2013) 122 (21): 4516.

https://doi.org/10.1182/blood.V122.21.4516.4516

Published: 2013

Journal Articles

Hematology and Oncology: Natural Allies Or Time To Part Ways? Results Of a Medicine Resident Survey

Esha Kaul, MD, John Paul Flores, MD, Jessica K Paulus, ScD, Krishna S. Gunturu, MBBS, MD

Blood (2013) 122 (21): 2920.

https://doi.org/10.1182/blood.V122.21.2920.2920

Published: 2013

Journal Articles

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Chakra P Chaulagain, MD, FACP, Esha Kaul, MD, Monika Pilichowska, MD, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD

Blood (2013) 122 (21): 5496.

https://doi.org/10.1182/blood.V122.21.5496.5496

Published: 2013

Journal Articles

Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity.

Gunjan L Shah, MD MS, Esha Kaul, MD, Shelly Fallo, RPh, Furha I. Cossor, MD MS, Hedy Smith, MD PhD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD

Blood (2012) 120 (21): 2968.

https://doi.org/10.1182/blood.V120.21.2968.2968

Published: 2012

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Less‑intensive therapy in newly diagnosed acute myeloid leuekmia (AML) in India: Real-world adoption and prognostic utility of ELN‑LI and ELN‑2022 classification

Pediatric inspired (BFM) protocol in adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL) in India: Real‑world treatment timelines and impact of delays on survival

Early use of talicabtagene autoleucel in r/r B-acute lymphoblastic leukemia is cost-effective: Improved efficacy, reduced toxicity and healthcare resource utilization support affordable access

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.

Real World Data of Novel Talicabtagene Autoleucel (humanized CD19 CAR-T) from India; Ensuring Equitable Access with Excellent Safety and Efficacy Profile

CD 19 CAR T-Cell Therapy in R/R B Cell Malignancies : A Real World Experience from CAR T Working Group, Delhi Ncr ,India

Photopheresis As Part of Conditioning Reduces Incidence of Severe Graft Versus Host Disease: Fourteen Year Follow-up of a Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis

Plerixafor and G-CSF For Autologous Stem Cell Mobilization In AL Amyloidosis: A Single Center Experience

Hematology and Oncology: Natural Allies Or Time To Part Ways? Results Of a Medicine Resident Survey

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only